In esophageal cancer cells, activation of NRF2 can upregulate the expression of antioxidant enzymes, including glutathione synthetase (GCLM) and glutathione peroxidase 4 (GPX4), which play an important role in the cell’s antioxidant defense41. Here, GCLM is linked to esophageal cancer.